Sutro Biopharma Aktie (A2N6SG

Was macht Sutro Biopharma?

Unternehmensprofil

Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.

Chart der Sutro Biopharma Aktie

Charttool öffnen

Aktuelle Nachrichten zu Sutro Biopharma

Weitere Nachrichten

Das berichten andere über Sutro Biopharma

Sutro Biopharma, Inc. (STRO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow

Sutro Biopharma, Inc. (STRO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Sutro Biopharma stock falls after announcing 1-for-10 reverse split By Investing.com

Sutro Biopharma stock falls after announcing 1-for-10 reverse split

Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Beats Revenue Estimates

Sutro Biopharma (STRO) delivered earnings and revenue surprises of +64.10% and +293.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies...